A novel liquid biopsy-based approach for highly specific cancer diagnostics: mitigating false responses in assaying patient plasma-derived circulating microRNAs through combined SERS and plasmon-enhanced fluorescence analyses is a research paper published in The Analyst (2020). On theSindex it has a DataRank of 0. It has been cited 41 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
Division of Chemical, Bioengineering, Environmental, and Transport Systems
Grant: 1604617
National Institutes of Health
Grant: UL1TR002529
National Institutes of Health
Grant: 5UL1TR002529-02
Indiana Clinical and Translational Sciences Institute
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals